NCCN 2017 Oncology Fellows Program: New Horizons in Quality Cancer Care™
The purpose of this well-regarded program is to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and other evidence-based treatment principles in the management of significant cancer types and supportive care issues.
This educational program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.
Following this program, participants should be able to:
Multidisciplinary Management of Esophageal and Esophagogastric Junction (EGJ) Cancers
• Develop an individualized treatment plan incorporating combined modality therapy for patients with locoregional esophageal and EGJ cancers based on the histology, tumor stage and anatomic location
• Identify patients with advanced or metastatic esophageal and EGJ cancers most likely to benefit from targeted therapies
Recognition and Management of Treatment-Induced Cardiac Toxicity in Cancer Survivors
• Recognize risk factors for the development of heart failure in cancer survivors
• Summarize the recommendations regarding screening for and treatment of anthracycline-induced cardiotoxicity in the NCCN Guidelines for Survivorship
Things A Oncology Fellow Needs to Know (That Won’t Be Taught in Fellowship)
• Interpret the major legislation that has shifted the clinical care landscape from one that is pay for quantity to one that is pay for value
• Describe the different care models and federal initiatives relevant to improving cancer care delivery
The Role of Imaging for Staging and Treatment Planning in Gynecologic Malignancies
• Outline the role of imaging in the evaluation, treatment, and surveillance of gynecologic malignancies
• Discuss appropriate applications of various imaging modalities in this patient population
Multidisciplinary Management of Head and Neck Cancer
• Evaluate the need for a multidisciplinary team in caring for patients with head and neck cancer
• Assess the supportive care needs of patients undergoing treatment for head and neck cancer, such as nutrition and dental evaluation and management
Combination Therapies for Advanced Melanoma
• For first-line treatment of advanced melanoma, list factors to consider when determining whether a patient should receive (1) a checkpoint immunotherapy versus a BRAF-targeted therapy and (2) a monotherapy versus a combination therapy
• For second-line or subsequent therapy in patients with advanced melanoma, list appropriate treatment options based on a patient’s response to prior therapy
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.